Paradigm Capital Analyst Discusses First Biosynthetics Cannabis Conference August 17, 2019 admin Marijuana Health Benefits 0 Paradigm Capital Equities Analyst for Healthcare and Biotechnology, Rahul Sarugaser, discusses the company’s biosynthetics cannabis conference on April 15, …
Be the first to comment